curcumin/Finding
One finding, on its own
A single claim from the graph, with the grade computed from its study, the sentence it was drawn from, and the paper. This address does not change.
No detected effect on visual analogue scale pain intensity
LikelyGrade B, Likely. Human evidence with one recorded weakness, or capped at B by its design or by unread numbers.FindingNull result“In the between-group analysis, no significant differences were observed in VAS hand pain at rest, VAS hand pain during activity, VAS hand morning stiffness, DASH score, hand grip, pinch strength and rescue drug usage at 1, 3, and 6 months.”
Quoted verbatim from Efficacy and safety of curcumin in patients with hand osteoarthritis: a pilot double-blinded randomised controlled trial.. - Study
- RCT
- Participants
- 27
- Dose
- 170 mg/day curcuminoids (turmeric powder capsules, 28.75 mg curcuminoids per capsule, two capsules three times daily) for 3 months
- Population
- patients over 50 years with hand osteoarthritis, pain during activity, between-group at 1, 3 and 6 months
Efficacy and safety of curcumin in patients with hand osteoarthritis: a pilot double-blinded randomised controlled trial.2025PMID:41053771Permalink
Keep reading
- Everything the graph holds on curcumin
- Every compound studied against Visual analogue scale pain intensity
- How to read the grade and the marks
To cite this finding: https://catalystproject.ai/e/01M3R55RP35YJS08RAGJX9788N